Psychiatric aspects of organic sleep disorders

Dialogues in Clinical Neuroscience

Volumn 7, Issue 4, 2005, Pages 335-346

  Haba Rubio, José ^a,b  

^a UNIVERSITY HOSPITAL   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Circadian sleep disorder; Idiopathic hypersomnia; Mood disorder; Narcolepsy; Periodic limb movement disorder; Quality of life; Restless legs syndrome; Sleep; Sleep apnea syndrome

Indexed keywords

AMPHETAMINE DERIVATIVE;

AGITATION; ANXIETY DISORDER; CIRCADIAN RHYTHM SLEEP DISORDER; DEPRESSION; DISEASE ASSOCIATION; HUMAN; HYPERSOMNIA; IDIOPATHIC DISEASE; INSOMNIA; IRRITABILITY; MENTAL DISEASE; MOOD DISORDER; MORBIDITY; NARCOLEPSY; QUALITY OF LIFE; RESTLESS LEGS SYNDROME; REVIEW; SCORING SYSTEM; SEXUAL DYSFUNCTION; SIDE EFFECT; SLEEP APNEA SYNDROME; SLEEP DISORDER;

HUMANS; HYPERSOMNOLENCE, IDIOPATHIC; MENTAL DISORDERS; NARCOLEPSY; NOCTURNAL MYOCLONUS SYNDROME; PSYCHIATRY; RESTLESS LEGS SYNDROME; SLEEP APNEA, OBSTRUCTIVE; SLEEP DISORDERS; SLEEP DISORDERS, CIRCADIAN RHYTHM;

EID: 30944456797     PISSN: 12948322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (144)

1. Mosko S, Zetin M, Glen S, et al. Self-reported depressive symptomatology, mood ratings, and treatment outcome in sleep disorder patients. J Clin Psychol. 1989;45:51-60.
2. Vandeputte M, de Weerd A. Sleep disorders and depressive feelings: a global survey with the Beck Depression Scale. Sleep Med. 2003;4:343-345.
3. Bardwell WA, Moore P, Ancoli-Israel S, Dimsdale JE. Fatigue in obstructive sleep apnea: Driven by depressive symptoms instead of apnea severity? Am J Psychiatry. 2003;160:350-355.
4. Guilleminault C, Anagnos A. Narcolepsy. In: Kryger MH, Roth T, Dement WC, eds. Principles and Practice of Sleep Medicine. 3rd ed. Philadelphia, Pa: WB Saunders; 2000:676-686.
5. Zeman A, Britton T, Douglas N, et al. Narcolepsy and excessive daytime sleepiness. BMJ. 2004;329:724-728.
6. Mitler MM, Gujavarty KS. Narcolepsy: when to suspect it and how to help. Consultant: J Med Consultation. 1982;4:215-224.
7. Broughton R, Ghanem Q, Hishikawa Y, Sugita Y, Nevsimalova S, Roth B. Life effects of narcolepsy in 180 patients from North America, Asia and Europe compared to matched controls. Can J Neurol Sci. 1981;8:299-304.
8. Beusterien KM, Rogers AE, Walsleben JA, et al. Health-related quality of life effects of modafinil for treatment of narcolepsy. Sleep. 1999;22:757-765.
9. Kales A, Soldatos CR, Bixler EO, et al. Narcolepsy-cataplexy. II. Psychosocial consequences and associated psychopathology. Arch Neurol. 1982;39:169-171.
10. Daniels E, King MA, Smith IE, Shneerson JM. Health-related quality of life in narcolepsy. J Sleep Res. 2001;10:75-81.
11. Aldrich MS. Automobile accidents in patients with sleep disorders. Sleep. 1989;12:487-494.
12. Findley L, Unverzagt M, Guchu R, Fabrizio M, Buckner J, Suratt P. Vigilance and automobile accidents in patients with sleep apnea or narcolepsy. Chest. 1995;108:619-624.
13. George CF, Boudreau AC, Smiley A. Comparison of simulated driving performance in narcolepsy and sleep apnea patients. Sleep. 1996;19:711-717.
14. Findley LJ, Suratt PM, Dinges DF. Time-on-task decrements in "steer clear" performance of patients with sleep apnea and narcolepsy. Sleep. 1999;22:804-809.
15. Mitler MM, Hajdukovic R, Erman MK. Treatment of narcolepsy with methamphetamine. Sleep. 1993;16:306-317.
16. Aguirre M, Broughton R, Stuss D. Does memory impairment exist in narcolepsy-cataplexy? J Clin Exp Neuropsychol. 1985;7:14-24.
17. Godbout R, Montplaisir J. All-day performance variations in normal and narcoleptic subjects. Sleep. 1986;9:200-204.
18. Rogers AE, Rosenberg RS. Tests of memory in narcoleptics. Sleep. 1990;13:42-52.
19. Hood B, Bruck D. Sleepiness and performance in narcolepsy. J Sleep Res. 1996;5:128-134.
20. Rieger M, Mayer G, Gauggel S. Attention deficits in patients with narcolepsy. Sleep. 2003;26:36-43.
21. Sours JA. Narcolepsy and other disturbances in the sleep-waking rhythm: a study of 115 cases with review of the literature. J Nerv Ment Dis. 1963;137:525-542.
22. Roy A. Psychiatric aspects of narcolepsy. Br J Psychiatry. 1976;128:562-565.
23. Krishnan RR, Volow MR, Miller PP, Carwile ST. Narcolepsy: preliminary retrospective study of psychiatric and psychosocial aspects. Am J Psychiatry. 1984;141:428-431.
24. Douglas NJ. The psychosocial aspects of narcolepsy. Neurology. 1998;50(2 suppl 1):S27-S30.
25. Vourdas A, Shneerson JM, Gregory CA, et al. Narcolepsy and psychopathology: is there an association? Sleep Med. 2002;3:353-360.
26. Rodin G, Voshart K. Depression in the medically ill: an overview. Am J Psychiatry. 1986;143:696-705.
27. Zwicker J, Bruck D, Parkes JD, Broughton RJ. Acute mood improvement after dextroamphetamine and methylphenidate in narcolepsy. J Sleep Res. 1995;4:252-255.
28. Goswami M. The influence of clinical symptoms on quality of life in patients with narcolepsy. Neurology. 1998;50(2 suppl 1):S31-S36.
29. Becker PM, Schwartz JR, Feldman NT, Hughes RJ. Effect of modafinil on fatigue, mood, and health-related quality of life in patients with narcolepsy. Psychopharmacology. 2004; 171:133-139.
30. DeBattista C, Lembke A, Solvason HB, Ghebremichael R, Poirier J. A prospective trial of modafinil as an adjunctive treatment of major depression. J Clin Psychopharmacol. 2004;24:87-90.
31. Berkowitz HL. Modafinil in poststroke depression. Psychosomatics. 2005;46:93.
32. Fava M, Thase ME, DeBattista C. A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness. J Clin Psychiatry. 2005;66:85-93.
33. Nasr S. Modafinil as adjunctive therapy in depressed outpatients. Ann Clin Psychiatry. 2004;16:133-138.
34. Lundt L. Modafinil treatment in patients with seasonal affective disorder/winter depression: an open-label pilot study. J Affect Disord. 2004;81:173-178.
35. Fernandes PP, Petty F. Modafinil for remitted bipolar depression with hypersomnia. Ann Pharmacother. 2003;37:1807-1809.
36. Roth B, Nevsimalova S. Depresssion in narcolepsy and hypersommia. Schweiz Arch Neurol Neurochir Psychiatr. 1975;116:291-300.
37. Adrien J. Neurobiological bases for the relation between sleep and depression. Sleep Med Rev. 2002;6:341-351.
38. Douglass AB, Hays P, Pazderka F, Russell JM. Florid refractory schizophrenias that turn out to be treatable variants of HLA-assodated narcolepsy. J Nerv Ment Dis. 1991;179:12-17.
39. Billiard M, Dauvilliers Y. Idiopathic hypersomnia. Sleep Med Rev. 2001;5:349-358.
40. Broughton R, Nevsimalova S, Roth B. The socioeconomic effects of idiopathic hypersomnia. In: Sleep. Romania: Tirgu-Mures; 1980:229-233.
41. Bassetti C, Aldrich MS. Idiopathic hypersomnia. A series of 42 patients. Brain. 1997;120:1423-1435.
42. American Academy of Sleep Medicine Task Force. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep. 1999;22:667-689.
43. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993;328:1230-1235.
44. Hla KM, Young TB, Bidwell T, Palta M, Skatrud JB, Dempsey J. Sleep apnea and hypertension. A population-based study. Ann Intern Med. 1994; 120:382-388.
45. Young T, Peppard P, Palta M, et al. Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med. 1997;157:1746-1752.
46. Findley LJ, Unverzagt ME, Suratt PM. Automobile accidents involving patients with obstructive sleep apnea. Am Rev Respir Dis. 1988;138:337-340.
47. Stoohs RA, Bingham LA, Itoi A, Guilleminault C, Dement WC. Sleep and sleep-disordered breathing in commercial long-haul truck drivers. Chest. 1995;107:1275-1282.
48. Barbe F, Pericas J, Munoz A, Findley L, Anto JM, Agusti AG. Automobile accidents in patients with sleep apnea syndrome. An epidemiological and mechanistic study. Am J Respir Crit Care Med. 1998;158:18-22.
49. Beebe DW, Gozal D. Obstructive sleep apnea and the prefrontal cortex: towards a comprehensive model linking nocturnal upper airway obstruction to daytime cognitive and behavioral deficits. J Sleep Res. 2002;11:1-16.
50. Verstraeten E, Cluydts R. Executive control of attention in sleep apnea patients: theoretical concepts and methodological considerations. Sleep Med Rev. 2004;8:257-267.
51. Cheshire K, Engleman H, Deary I, Shapiro C, Douglas NJ. Factors impairing daytime performance in patients with sleep apnea/hypopnea syndrome. Arch Intern Med. 1992;152:538-541.
52. Borak J, Cieslicki J, Szelenberger W, Wilczak-Szadkowska H, Koziej M, Zielinski J. Psychopathological characteristics of the consequences of obstructive sleep apnea prior to and 3 months after therapy. Psychiatr Pol. 1993;27:43-55.
53. Borak J, Cieslicki JK, Koziej M, Matuszewski A, Zielinski J. Effects of CPAP treatment on psychological status in patients with severe obstructive sleep apnoea. J Sleep Res. 1996;5:123-127.
54. Edlund MJ, McNamara ME, Millman RP. Sleep apnea and panic attacks. Compr Psychiatry. 1991;32:130-132.
55. Lee S, Chiu HF, Chen CN. Psychosis in sleep apnoea. Aust N Z J Psychiatry. 1989;23:571-573.
56. Bassiri AG, Guilleminault C. Clinical features and evaluation of obstructive sleep apnea-hypopnea syndrome. In: Kryger MH, Roth T, Dement WC, eds. Principles and Practice of Sleep Medicine. 3rd ed. Philadelphia, Pa: WB Saunders; 2000:869-878.
57. Guilleminault C, Eldridge FL, Tilkian A, Simmons FB, Dement WC. Sleep apnea syndrome due to upper airway obstruction: a review of 25 cases. Arch Intern Med. 1977;137:296-300.
58. Reynolds CF 3rd, Kupfer DJ, McEachran AB, Taska LS, Sewitch DE, Coble PA. Depressive psychopathology in male sleep apneics. J Clin Psychiatry. 1984;45:287-290.
59. Kales A, Caldwell AB, Cadieux RJ, Vela-Bueno A, Ruch LG, Mayes SD. Severe obstructive sleep apnea. II. Associated psychopathology and psychosocial consequences. J Chronic Dis. 1985;38:427-434.
60. Aikens JE, Mendelson WB. A matched comparison of MMPI responses in patients with primary snoring or obstructive sleep apnea. Sleep. 1999;22:355-359.
61. Akashiba T, Kawahara S, Akahoshi T, et al. Relationship between quality of life and mood or depression in patients with severe obstructive sleep apnea syndrome. Chest. 2002;122:861-865.
62. Yue W, Hao W, Liu P, Liu T, Ni M, Guo Q. A case-control study on psychological symptoms in sleep apnea-hypopnea syndrome. Can J Psychiatry. 2003;48:318-323.
63. Sink J, Bliwise DL, Dement WC. Self-reported excessive daytime somnolence and impaired respiration in sleep. Chest. 1986;90:177-180.
64. Bliwise DL, Yesavage JA, Sink J, Widrow L, Dement WC. Depressive symptoms and impaired respiration in sleep. J Consult Clin Psychol. 1986;54:734-735.
65. Klonoff H, Fleetham J, Taylor DR, Clark C. Treatment outcome of obstructive sleep apnea. Physiological and neuropsychological concomitants. J Nerv Ment Dis. 1987;175:208-212.
66. Lee S. Depression in sleep apnea: a different view. J Clin Psychiatry. 1990;51:309-310.
67. Flemons WW, Whitelaw WA, Brant R, Remmers JE. Likelihood ratios for a sleep apnea clinical prediction rule. Am J Respir Crit Care Med. 1994;150:1279-1285.
68. Pillar G, Lavie P. Psychiatric symptoms in sleep apnea syndrome: effects of gender and respiratory disturbance index. Chest. 1998;114:697-703.
69. Means MK, Lichstein KL, Edinger JD, et al. Changes in depressive symp toms after continuous positive airway pressure treatment for obstructive sleep apnea. Sleep Breath. 2003;7:31-42.
70. Millman RP, Fogel BS, McNamara ME, Carlisle CC. Depression as a manifestation of obstructive sleep apnea: reversal with nasal continuous positive airway pressure. J Clin Psychiatry. 1989;50:348-351.
71. Bardwell WA, Berry CC, Ancoli-Israel S, Dimsdale JE. Psychological correlates of sleep apnea. J Psychosom Res. 1999;47:583-596.
72. Sforza E, de Saint Hilaire Z, Pelissolo A, Rochat T, Ibanez V. Personality, anxiety and mood traits in patients with sleep-related breathing disorders: effect of reduced daytime alertness. Sleep Med. 2002;3:139-145.
73. Aloia MS, Arnedt JT, Smith L, Skrekas J, Stanchina M, Millman RP. Examining the construct of depression in obstructive sleep apnea syndrome. Sleep Med. 2005;6:115-121.
74. Weaver TE, Laizner AM, Evans LK, et al. An instrument to measure functional status outcomes for disorders of excessive sleepiness. Sleep. 1997;20:835-843.
75. Flemons WW, Tsai W. Quality of life consequences of sleep-disordered breathing. J Allergy Clin Immunol. 1997;99:S750-S756.
76. Flemons WW, Reimer MA. Measurement properties of the Calgary Sleep Apnea Quality of Life Index. Am J Respir Crit Care Med. 2002;165:159-164.
77. Meslier N, Lebrun T, Grillier-Lanoir V, et al. A French survey of 3225 patients treated with CPAP for obstructive sleep apnoea: benefits, tolerance, compliance and quality of life. Eur Respir J. 1998;12:185-192.
78. Sanner BM, Klewer J, Trumm A, Randerath W, Kreuzer I, Zidek W. Long-term treatment with continuous positive airway pressure improves quality of life in obstructive sleep apnoea syndrome. Eur Respir J. 2000;16:118-122.
79. Jokic R, Klimaszewski A, Crossley M, Sridhar G, Fitzpatrick MF. Positional treatment vs continuous positive airway pressure in patients with positional obstructive sleep apnea syndrome. Chest. 1999;115:771-781.
80. Fornas C, Ballester E, Arteta E, et al. Measurement of general health status in obstructive sleep apnea hypopnea patients. Sleep. 1995;18:876-879.
81. Bennett LS, Barbour C, Langford B, Stradling JR, Davies RJ. Health status in obstructive sleep apnea: relationship with sleep fragmentation and daytine sleepiness, and effects of continuous positive airway pressure treatment. Am J Respir Crit Care Med. 1999;159:1884-1890.
82. Yang EH, Hla KM, McHorney CA, Havighurst T, Badr MS, Weber S. Sleep apnea and quality of life. Sleep. 2000;23:535-541.
83. Engleman HM, Kingshott RN, Wraith PK, Mackay TW, Deary IJ, Douglas NJ. Randomized placebo-controlled crossover trial of continuous positive airway pressure for mild sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med. 1999;159:461-467.
84. Sforza E, Janssens JP, Rochat T, Ibanez V. Determinants of altered quality of life in patients with sleep-related breathing disorders. Eur Respir J. 2003;21:682-687.
85. Derderian SS, Bridenbaugh RH, Rajagopal KR. Neuropsychologic symptoms in obstructive sleep apnea improve after treatment with nasal continuous positive airway pressure. Chest. 1988;94:1023-1027.
86. Engleman HM, Cheshire KE, Deary IJ, Douglas NJ. Daytime sleepiness, cognitive performance and mood after continuous positive airway pressure for the sleep apnoea/hypopnoea syndrome. Thorax. 1993;48:911-914.
87. Engleman HM, Martin SE, Deary IJ, Douglas NJ. Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome. Lancet. 1994;343:572-575.
88. Engleman HM, Martin SE, Deary IJ, Douglas NJ. Effect of CPAP therapy on daytime function in patients with mild sleep apnoea/hypopnoea syndrome. Thorax. 1997;52:114-119.
89. Yamamoto H, Akashiba T, Kosaka N, Ito D, Horie T. Long-term effects nasal continuous positive airway pressure on daytime sleepiness, mood and traffic accidents in patients with obstructive sleep apnoea. Respir Med. 2000;94:87-90.
90. Engleman HM, Martin SE, Kingshott RN, Mackay TW, Deary IJ, Douglas NJ. Randomised placebo controlled trial of daytime function after continuous positive airway pressure (CPAP) therapy for the sleep apnoea/hypopnoea syndrome. Thorax. 1998;53:341-345.
91. Munoz A, Mayoralas LR, Barbe F, Pericas J, Agusti AG. Long-term effects of CPAP on daytime functioning in patients with sleep apnoea syndrome. Eur Respir J. 2000;15:676-681.
92. Bloom JW, Kaltenborn WT, Quan SF. Risk factors in a general population for snoring. Importance of cigarette smoking and obesity. Chest. 1988;93:678-683.
93. Phillips B, Cook Y, Schmitt F, Berry D. Sleep apnea: prevalence of risk factors in a general population. South Med J. 1989;82:1090-1092.
94. Rajala R, Partinen M, Sane T, Pelkonen R, Huikuri K, Seppalainen AM. Obstructive sleep apnoea syndrome in morbidly obese patients. J Intern Med. 1991;230:125-129.
95. Levinson PD, McGarvey ST, Carlisle CC, Eveloff SE, Herbert PN, Millman RP. Adiposity and cardiovascular risk factors in men with obstructive sleep apnea. Chest. 1993;103:1336-1342.
96. Grunstein R, Wilcox I, Yang TS, Gould Y, Hedner J. Snoring and sleep apnoea in men: association with central obesity and hypertension. Int J Obes Relat Metab Disord. 1993;17:533-540.
97. Dealberto MJ, Ferber C, Garma L, Lemoine P, Alperovitch A. Factors related to sleep apnea syndrome in sleep clinic patients. Chest. 1994;105:1753-1758.
98. Wooley SC, Garner DM. Obesity treatment: the high cost of false hope. J Am Diet Assoc. 1991;9:1248-1251.
99. Black DW, Goldstein RB, Mason EE. Prevalence of mental disorder in 88 morbidly obese bariatric clinic patients. Am J Psychiatry. 1992;149:227-234.
100. Goldstein LT, Goldsmith SJ, Anger K, Leon AC. Psychiatric symptoms in clients presenting for commercial weight reduction treatment. Int J Eat Disord. 1996;20:191-197.
101. Carpenter KM, Hasin DS, Allison DB, Faith MS. Relationships between obesity and DSM-IV major depressive disorder, suicide ideation, and suicide attempts: results from a general population study. Am J Public Health. 2000;90:251-257.
102. Walters AS. Toward a better definition of the restless legs syndrome. Mov Disord. 1995;10:634-642.
103. Montplaisir J, Boucher S, Poirier G, Lavigne G, Lapierre O, Lesperance P. Clinical, polysomnographic and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria. Mov Disord. 1997;12:61-65.
104. American Sleep Disorder Association. Recording and scoring leg movements. Sleep. 1993;16:748-759.
105. American Sleep Disorder Association. The International Classification of Sleep Disorders, Revised: Diagnostic and Coding Manual. Rochester, Minn: American Academy of Sleep Medicine; 1997.
106. Eisensehr I, Ehrenberg BL, Noachtar S. Different sleep characteristics in restless legs syndrome and periodic limb movement disorder. Sleep Med. 2003;4:147-152.
107. Lavigne GJ, Montplaisir JY. Restless legs syndrome and sleep bruxism: prevalence and association among Canadians. Sleep. 1994;17:739-743.
108. Phillips B, Young T, Finn L, Asher K, Hening WA, Purvis C. Epidemiology of restless legs symptoms in adults. Arch Intern Med. 2000;160: 2137-2141.
109. Bixler EO, Kales A, Vela-Bueno A, Jacoby JA, Scarone S, Soldatos CR. Nocturnal myoclonus and nocturnal myoclonic activity in the normal population. Res Commun Chem Pathol Pharmacol. 1982;36:129-140.
110. Coleman RM, Miles LE, Guilleminault CC, Zarcone VP Jr, van den Hoed J, Dement WC. Sleep-wake disorders in the elderly: polysomnographic analysis. J Am Geriatr Soc. 1981;29:289-296.
111. Earley CJ. Clinical practice. Restless legs syndrome. N Engl J Med. 2003;348:2103-2109.
112. Wittmaack T. Pathologie und Therapie der Sensibilitäts-Neurosen. Leipzig, Germany: E. Schäfer; 1861:459.
113. Gorman CA, Dyck PJ, Pearson JS. Symptoms of restless legs. Arch Intern Med. 1965;115:155-160.
114. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology: a report from the Restless Legs Syndrome Diagnosis and Epidemiology Workshop at the National Institutes of Health. Sleep Med. 2003;4:101-119.
115. Benes H, Kurella B, Kummer J, Kazenwadel J, Selzer R, Kohnen R. Rapid onset of action of levodopa in restless legs syndrome: a double-blind, randomized, multicenter, crossover trial. Sleep. 1999;22:1073-1081.
116. 2-agonist cabergoline-an open clinical trial. Sleep. 2000;23:349-354.
117. Abetz L, Allen R, Follet A, et al. Evaluating the quality of life of patients with restless legs syndrome. Clin Ther. 2004;26:925-935.
118. Rothdach AJ, Trenkwalder C, Haberstock J, Keil U, Berger K. Prevalence and risk factors of RLS in an elderly population: the MEMO study. Memory and Morbidity in Augsburg Elderly. Neurology. 2000;54:1064-1068.
119. Banno K, Delaive K, Walld R, Kryger MH. Restless legs syndrome in 218 patients: associated disorders. Sleep Med. 2000;1:221-229.
120. Berkowitz HL. Restless legs syndrome disguised as an affective disorder. Psychosomatics. 1984;25:336-337.
121. Ford DE, Kamerow DB. Epidemiologie study of sleep disturbances and psychiatric disorders. An opportunity for prevention? JAMA. 1989;262:1479-1484.
122. Breslau N, Roth T, Rosenthal L, Andreski P. Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults. Biol Psychiatry. 1996;39:411-418.
123. Ulfberg J, Nystrom B, Carter N, Edling C. Prevalence of restless legs syndrome among men aged 18 to 64 years: an association with somatic disease and neuropsychiatric symptoms. Mov Disord. 2001;16:1159-1163.
124. Saletu M, Anderer P, Saletu B, Lindeck-Pozza L, Hauer C, Saletu-Zyhlarz G. EEG mapping in patients with restless legs syndrome as compared with normal controls. Psychiatry Res. 2002;115:49-61.
125. Sevim S, Dogu O, Kaleagasi H, Aral M, Metin O, Camdeviren H. Correlation of anxiety and depression symptoms in patients with restless legs syndrome: a population based survey. J Neurol Neurosurg Psychiatry. 2004;75:226-230.
126. Winkelmann J, Prager M, Lieb R, et al. "Anxietas tibiarum." Depression and anxiety disorders in patients with restless legs syndrome. J Neurol. 2005;252:67-71.
127. Haba-Rubio J, Krieger J. Restless legs syndrome and periodic limb movements disorder. EMC-Neurologie. 2005;2:93-103.
128. Mendelson WB. Are periodic leg movements associated with clinical sleep disturbance? Sleep. 1996;19:219-223.
129. Saletu B, Anderer P, Saletu M, Hauer C, Lindeck-Pozza L, Saletu-Zyhlarz G. EEG mapping, psychometric, and polysomnographic studies in restless legs syndrome (RLS) and periodic limb movement disorder (PLMD) patients as compared with normal controls. Sleep Med. 2002;(3 suppl):535-S42.
130. Aikens JE, Vanable PA, Tadimeti L, Caruana-Montaldo B, Mendelson WB. Differential rates of psychopathology symptoms in periodic limb movement disorder, obstructive sleep apnea, psychophysiological insomnia, and insomnia with psychiatric disorder. Sleep. 1999;22:775-780.
131. Zorick F, Kribbs N, Roehrs T, Roth T. Polysomnographic and MMPI characteristics of patients with insomnia. Psychopharmacology Suppl. 1984;1:2-10.
132. Monk TH, Welsh DK. The role of chronobiology in sleep disorders medicine. Sleep Med Rev. 2003;7:455-473.
133. Katz G, Durst R, Zislin Y, Barel Y, Knobler HY Psychiatric aspects of jet lag: review and hypothesis. Med Hypotheses. 2001;56:20-23.
134. Jauhar P, Weller MP. Psychiatric morbidity and time zone changes: a study of patients from Heathrow airport. Br J Psychiatry. 1982;140:231-235.
135. Wehr TA, Wirz-Justice A. Circadian rhythm mechanisms in affective illness and in antidepressant drug action. Pharmacopsychiatria. 1982;15:31-39.
136. Wright JB. Mania following sleep deprivation. Br J Psychiatry. 1993;163:679-680.
137. Flinn DE. Transient psychotic reactions during travel. Am J Psychiatry. 1962;119:173-174.
138. Drake CL, Roehrs T, Richardson G, Walsh JK, Roth T. Shift work sleep disorder: prevalence and consequences beyond that of symptomatic day workers. Sleep. 2004;27:1453-1462.
139. Ohayon MM, Lemoine P, Arnaud-Briant V, Dreyfus M. Prevalence and consequences of sleep disorders in a shift worker population. J Psychosom Res. 2002;53:577-583.
140. Smith L, Folkard S, Poole CJ. Increased injuries on night shift. Lancet. 1994;344:1137-1139.
141. Segawa K, Nakazawa S, Tsukamoto Y, et al. Peptic ulcer is prevalent among shift workers. Dig Dis Sci. 1987;32:449-453.
142. Baker SK, Zee PC. Circadian disorders of the sleep-wake cycle. In: Kryger MH, Roth T, Dement WC, eds. Principles and Practice of Sleep Medicine. 3rd ed. Philadelphia, Pa: WB Saunders; 2000:606-614.
143. Shirayama M, Shirayama Y, Iida H, et al. The psychological aspects of patients with delayed sleep phase syndrome (DSPS). Sleep Med. 2003;4:427-433.
144. Regestein QR, Monk TH. Delayed sleep phase syndrome: a review of its clinical aspects. Am J Psychiatry. 1995;152:602-608.